News ArticleFractal Analytics Utilizes Rs. 82.1 Crore of IPO Fresh Issue Proceeds in Q2 FY27, CARE Ratings Confirms
Monitoring Agency Report for quarter ended September 30, 2026, verifies adherence to IPO fund utilization plans with no deviations
Fractal Analytics Limited disclosed a Monitoring Agency Report confirming compliance with utilization of Rs. 82.1 crore from its Rs. 1,023.5 crore IPO fresh issue proceeds in Q2 FY27 for product development, marketing, and equipment. The report by CARE Ratings for the quarter ended September 30, 2026, affirms no deviations from the IPO objectives.
Fractal Analytics Limited
Legal / Regulatory
Fractal Analytics Limited has utilized Rs. 82.1 crore from its Rs. 1,023.5 crore IPO fresh issue proceeds during the quarter ended September 30, 2026, primarily for product development, marketing, and employee equipment, with no deviations reported by CARE Ratings, the appointed Monitoring Agency.
The Monitoring Agency Report issued by CARE Ratings Limited confirms that Fractal Analytics adhered strictly to the objects disclosed in its IPO prospectus dated February 11, 2026.
During Q2 FY27, the company spent Rs. 10.3 crore on laptops and Rs. 71.1 crore on manpower and cloud-related costs supporting its Fractal.ai and Fractal Alpha product segments, key to product development and sales strategies.
The overall IPO fresh issue size was Rs. 1,023.5 crore, netting Rs. 959.3 crore after issue expenses, with no material deviations or shareholder approvals required for fund utilization as verified by several CA certificates and company records.
Fractal Analytics offered 3,15,57,305 equity shares in its IPO, including a fresh issue and offer for sale, at Rs. 900 per share, resulting in a total consideration of Rs. 2,833.9 crore.
Highlights
- No deviation from IPO objects reported for Q2 FY27 utilization of fresh issue proceeds
- Rs. 82.1 crore utilized including Rs. 10.3 crore on laptops and Rs. 71.1 crore on manpower and cloud costs
- IPO fresh issue size of Rs. 1,023.5 crore with net proceeds of Rs. 959.3 crore
- Offer was oversubscribed approximately 2.7 times with shares allotted to eligible employees at a discount
- Monitoring Agency CARE Ratings confirmed compliance based on certificates and financial documents
Key Data Snapshot
What happened
- Fractal Analytics utilized Rs. 82.1 crore of net IPO fresh issue proceeds during the quarter ended September 30, 2026.
- The company made expenditures primarily on product development (manpower and cloud costs) and purchase of laptops.
- CARE Ratings Limited, appointed as the Monitoring Agency for the IPO, reported no deviation from the objects disclosed in the IPO prospectus.
Key details
- The IPO comprised a fresh issue of Rs. 1,023.5 crore and an offer for sale aggregating Rs. 1,810.4 crore.
- The fresh issue shares were offered at Rs. 900 each, including an employee reservation portion at a discount of Rs. 85 per share.
- The overall IPO was oversubscribed about 2.7 times with allotment completed in February 2026.
- Issue expenses related to the fresh issue were Rs. 64.2 crore, leading to net proceeds of Rs. 959.3 crore available for utilization.
- The Monitoring Agency’s report is based on certified financial documents, management and CA certificates, and bank statements.
Regulatory and governance context
- The Monitoring Agency Report complies with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.
- No material deviations or shareholder approvals were noted or required regarding the utilization of IPO proceeds.
- Monitoring Agency affirms it performs no audit or independent verification beyond reviewing specified documents and notes it holds no conflict of interest in its role.
Highlights
- No deviation from IPO objects reported for Q2 FY27 utilization of fresh issue proceeds
- Rs. 82.1 crore utilized including Rs. 10.3 crore on laptops and Rs. 71.1 crore on manpower and cloud costs
- IPO fresh issue size of Rs. 1,023.5 crore with net proceeds of Rs. 959.3 crore
- Offer was oversubscribed approximately 2.7 times with shares allotted to eligible employees at a discount
- Monitoring Agency CARE Ratings confirmed compliance based on certificates and financial documents
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018
- Section 2(38) of the Companies Act, 2013
Promoters include Srikanth Velamakanni, Pranay Agrawal, Chetana Kumar, Narendra Kumar Agrawal, and Rupa Krishnan Agrawal
More News on Legal / Regulatory
View allLatest corporate announcements and market updates in Legal / Regulatory.
Dhoot Transmission Limited Confirms Full Utilization of Rs. 1400 Crore IPO Proceeds in Q2 FY27 as Per Monitoring Agency Report
Dhoot Transmission Limited has submitted the Monitoring Agency Report from CARE Ratings Limited for the quarter ended September 30, 2026, confirming that the Rs. 1400 crore fresh issue proceeds raised through its IPO have been fully and appropriately utilized according to the offer document.
Read Full Story
CORONA Remedies Limited Receives ₹4.88 Crore Demand Notice from NPPA Alleging Pricing Violation
CORONA Remedies Limited announced that it received a demand notice from the National Pharmaceutical Pricing Authority (NPPA) dated November 3, 2026, alleging a violation of the Drugs (Prices Control) Order, 2013, with a total demand amounting to ₹4,87,97,160 including interest and penalty.
Read Full Story
Max Healthcare Institute Limited Reports Ongoing Legal Proceedings at NCLT with Next Hearing on December 14, 2026
Max Healthcare Institute Limited has disclosed ongoing litigation at the National Company Law Tribunal (NCLT) Cuttack Bench involving its subsidiary Kalinga Hospital Ltd and other shareholders, with the next NCLT hearing scheduled for December 14, 2026.
Read Full Story
